Please login to read the full article.
Scrip Regulatory Affairs
EU's proposed risk-based approach to IVD regulation gets majority support
24 February 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- Australia explains regulatory requirements for in-house IVDs
- GHTF consults on various device-related field corrective actions and their risk classification
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
